Jane Street’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$957K Sell
34,499
-19,203
-36% -$548K ﹤0.01% 6601
2025
Q4
$1.83M Buy
53,702
+19,874
+59% +$640K ﹤0.01% 4981
2025
Q3
$866K Buy
+33,828
New +$742K ﹤0.01% 6633
2024
Q1
Sell
-3,742
Closed -$36.8K 9147
2023
Q4
$36.8K Buy
+3,742
New +$35.6K ﹤0.01% 8838
2023
Q2
Sell
-2,025
Closed -$20.4K 8639
2023
Q1
$20.4K Sell
2,025
-4,388
-68% -$74K ﹤0.01% 8639
2022
Q4
$100K Buy
6,413
+5,480
+587% +$93.7K ﹤0.01% 8093
2022
Q3
$18K Sell
933
-1,605
-63% -$38.8K ﹤0.01% 9223
2022
Q2
$64K Buy
2,538
+1,456
+135% +$33.5K ﹤0.01% 8842
2022
Q1
$27K Buy
+1,082
New +$23.2K ﹤0.01% 9858
2021
Q3
Sell
-3,009
Closed -$140K 9884
2021
Q2
$140K Buy
3,009
+1,892
+169% +$93.7K ﹤0.01% 9090
2021
Q1
$62K Buy
1,117
+165
+17% +$10.9K ﹤0.01% 8788
2020
Q4
$69K Buy
952
+32
+3% +$3.75K ﹤0.01% 7279
2020
Q3
$182K Buy
+920
New +$232K ﹤0.01% 6488
2018
Q2
Sell
-346
Closed -$204K 4938
2018
Q1
$204K Buy
+346
New +$215K ﹤0.01% 4432
2014
Q3
Sell
-1,570
Closed -$123K 2517
2014
Q2
$123K Buy
+1,570
New +$111K ﹤0.01% 2328
2013
Q3
Sell
-234
Closed -$34K 2690
2013
Q2
$34K Buy
+234
New +$36.7K ﹤0.01% 2571

Other funds holding ASMB

Jane Street's ASMB Position: Q1 2026 in Review

Jane Street reduced its Assembly Biosciences (ASMB) stake by 36% in Q1 2026, selling an estimated $548K and leaving 34,499 shares worth $957K. The position accounts for ﹤0.01% of the portfolio, ranked #6601.

Jane Street first reported a position in ASMB in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.83M in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Jane Street held 34,499 shares of Assembly Biosciences worth $957K as of Q1 2026.
  • Jane Street sold 19,203 Assembly Biosciences shares in Q1 2026, an estimated $548K.
  • Assembly Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6601 holding.
  • Jane Street first reported a position in Assembly Biosciences in Q2 2013 and has held it in 16 quarters since.
  • Jane Street's Assembly Biosciences position peaked at $1.83M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.